These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 7295103

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Removal of uraemic toxins by haemofiltration with different membranes. The benefit of regenerating haemofiltrate using a newly developed system.
    Jörstad S, Smeby LC, Wideröe TE, Berg KJ.
    Proc Eur Dial Transplant Assoc; 1979; 16():212-7. PubMed ID: 548983
    [Abstract] [Full Text] [Related]

  • 4. Transport of small, middle, and large molecular weight substances in a dual filtration artificial kidney.
    Smeby LC, Jörstad S, Wideröe TE, Svartaas TM.
    Artif Organs; 1981; 4 Suppl():104-9. PubMed ID: 7295075
    [Abstract] [Full Text] [Related]

  • 5. The effect of hemodialysis on endogenous middle molecules in uremic patients.
    Asaba H, Fürst P, Oulés R, Yahiel V, Zimmerman L, Bergström J.
    Clin Nephrol; 1979 May; 11(5):257-66. PubMed ID: 455822
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vitro cytotoxic properties of plasma fractions from uremic patients.
    Delaporte C, Gros F, Jonsson C, Bergström J.
    Artif Organs; 1981 May; 4 Suppl():68-70. PubMed ID: 7295099
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Removal of uremic toxins and regeneration of hemofiltrate by a selective dual hemofiltration artificial kidney (SEDUFARK) system.
    Jørstad S, Smeby LC, Widerøe TE, Berg KJ.
    Clin Nephrol; 1980 Feb; 13(2):85-92. PubMed ID: 6988123
    [Abstract] [Full Text] [Related]

  • 12. Blood levels of middle molecules and their effects on motor nerve conduction velocity.
    Botella J, Gea T, Sanz-Guajardo D, Criado M, Torres MT, Guardiola J.
    Artif Organs; 1981 Feb; 4 Suppl():151-5. PubMed ID: 7295082
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 15. [Short-term dialyses using the Rhodial system].
    Lichtenberg R.
    Z Urol Nephrol; 1978 Jul; 71(7):433-43. PubMed ID: 696018
    [Abstract] [Full Text] [Related]

  • 16. [Clinical and metabolic consequences of uremic toxicity].
    Rutkowski P.
    Przegl Lek; 2006 Jul; 63(4):209-17. PubMed ID: 17080744
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.